We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
-16.22%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.33B
AUM Growth
-$303M
(-19%)
Cap. Flow
-$2.32M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
36.19%
Holding
237
New
8
Increased
84
Reduced
90
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradyne
TER
|
+$4.42M |
| 2 |
Medtronic
MDT
|
+$1.99M |
| 3 |
Procter & Gamble
PG
|
+$1.78M |
| 4 |
Rockwell Automation
ROK
|
+$1.64M |
| 5 |
Aptiv
APTV
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$9.71M |
| 2 |
PayPal
PYPL
|
+$5.72M |
| 3 |
Unilever
UL
|
+$3.05M |
| 4 |
Amazon
AMZN
|
+$1.36M |
| 5 |
Pacific Biosciences
PACB
|
+$1.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.75% |
| 2 | Technology | 22.62% |
| 3 | Industrials | 13.8% |
| 4 | Communication Services | 10.76% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.94B
| – | – |
-5,494
| Closed | -$209K |
|
|
GAM
227
General American Investors Company
GAM
$1.61B
| – | – |
-7,618
| Closed | -$324K |
|
228
iShares Russell 2000 ETF
IWM
$82.2B
| – | – |
-1,085
| Closed | -$223K |
|
|
229
Pacific Biosciences
PACB
$345M
| – | – |
-113,480
| Closed | -$1.03M |
|
230
Plexus
PLXS
$7.25B
| – | – |
-4,080
| Closed | -$334K |
|
231
Invesco QQQ Trust
QQQ
$481B
| – | – |
-1,096
| Closed | -$397K |
|
232
Qorvo
QRVO
$8.67B
| – | – |
-2,000
| Closed | -$248K |
|
233
Senseonics Holdings Inc
SENS
$419M
| – | – |
-865
| Closed | -$34K |
|
234
Skyworks Solutions
SWKS
$10.5B
| – | – |
-1,800
| Closed | -$240K |
|
235
Vanguard Morningstar Mid-Cap ETF
VO
$110B
| – | – |
-12,432
| Closed | -$739K |
|
|
DM
236
DELISTED
Desktop Metal, Inc.
DM
| – | – |
-1,949
| Closed | -$92K |
|
|
ATRS
237
DELISTED
Antares Pharma, Inc.
ATRS
| – | – |
-65,490
| Closed | -$269K |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
NIM
C
Reynders McVeigh Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Reynders McVeigh Capital Management held 237 positions worth $1.33B, down 19% from $1.64B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Reynders McVeigh Capital Management's Q2 2022 filing shows 8 new, 84 increased, 90 reduced and 19 closed positions. Its largest new stake was Aptiv: 13,046 shares worth $1.16M. The largest sale was Apple, an estimated $9.71M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
- Reynders McVeigh Capital Management's largest Q2 2022 buy was Aptiv: 13,046 shares worth $1.16M.
- Reynders McVeigh Capital Management added most to Teradyne in Q2 2022, an estimated $4.42M increase.
- Reynders McVeigh Capital Management's biggest Q2 2022 reduction was Apple, cutting an estimated $9.71M.
- Reynders McVeigh Capital Management fully exited Pacific Biosciences in Q2 2022, selling an estimated $1.03M.
- Reynders McVeigh Capital Management's ten largest holdings make up 36% of its $1.33B portfolio in Q2 2022.
- Reynders McVeigh Capital Management opened 8 new positions and closed 19 in Q2 2022.
- Reynders McVeigh Capital Management's portfolio value fell 19% quarter-over-quarter to $1.33B.
Based on Reynders McVeigh Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.